Bio Green Med Solution, Inc.
Bio Green Med Solution specializes in supplying and trading protective and fire safety equipment, serving commercial, industrial, healthcare, residential, government and retail customers. Its main business is conducted through Fitters Sdn. Bhd., which distributes fire extinguishers, fire protection systems, fire-resistant doors, personal protective equipment and safety apparel. Brands include FITTERS FIRE-X extinguishers, PYRODOR fire doors, and PYROSUIT® and SAFEFITT® protective garments. The company also offers custom tailoring of safety apparel and provides design, installation, testing and commissioning for foam systems. Bio Green Med Solution makes money through product sales and distribution, as well as related services for foam systems. Its operations are based in Malaysia, with its head office in Kuala Lumpur and regional warehouses and logistics partners across the country.
No SEC Form 4 filings for $BGMS in the last 30 days.
See all $BGMS insider activity →Bio Green Med Solution reported Q3 2026 revenue of $454,000, up from $81,000 a year earlier, and a net loss of $449,000, down from $988,000. Operating loss was $520,000, with a 25% gross margin on fire safety equipment. Cash reserves were $3.454 million. The company plans a shareholder meeting for a proposed business combination with Future NRG Sdn. Bhd.
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, November 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of f
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events . On October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BGMS (Bio Green Med Solution, Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent BGMS coverage spans earnings, corporate actions and financial news.
The company posted a modest revenue increase but a sizable net loss, indicating ongoing financial challenges.
Quarterly loss improvement and cash balance may support modest upside.
Dividend announcement may provide modest support to the stock.
The filing adds concrete capital structure and cash runway details, plus a potential ownership shift via the FNRG exchange, which can affect dilution and control expectations.
Routine corporate governance outcomes; limited direct impact on near-term fundamentals, but confirms board/auditor continuity.
AlphAI scores every news story that mentions BGMS with an AI model for sentiment and relevance, and aggregates insider trades from Bio Green Med Solution, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Bio Green Med Solution reported Q3 2026 revenue of $454,000, up from $81,000 a year earlier, and a net loss of $449,000, down from $988,000. Operating loss was $520,000, with a 25% gross margin on fire safety equipment. Cash reserves were $3.454 million. The company plans a shareholder meeting for a proposed business combination with Future NRG Sdn. Bhd.
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, November 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of f
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events . On October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fi
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001130166 0001130166 2026-06-18 2026-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2026 D
Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “ Agreement ”) is dated as of June 10, 2026 (the “Effective Date”), between Bio Green Med Solution, Inc., a Delaware corporation (the “ Company ”), and _______, an ind
Bio Green Med Solution (NASDAQ:BGMS) shares rose about 123% to $2.35 after it signed an all-stock business combination agreement with Malaysia-based Future NRG. Future NRG will become a wholly owned BGMS subsidiary; the combined firm is expected to trade on Nasdaq under BGMS, led by Datuk Dr. Doris Wong Sing Ee. The deal is expected to close in Q4 2026, pending shareholder approval and SEC registration.
Bio Green Med Solution Inc. reported a Q4 net income of -$611 Thousand. This brief announcement from Refinitiv provides a key financial update for the company. The article focuses solely on this financial figure without further elaboration.
Ong Yee Lung has filed an amendment to Schedule 13G/A for Bio Green Med Solution, Inc. (BGMS), reporting zero beneficial ownership of the company's common stock. This filing indicates that Ong Yee Lung holds 0 shares, representing 0% of BGMS, and has no voting or dispositive power over any shares. The amendment, dated March 13, 2026, is considered to have a neutral sentiment and moderate impact on corporate governance.
This article highlights 12 healthcare stocks experiencing significant price movements during Friday's intraday trading session. It details both the top gainers, such as Ironwood Pharmaceuticals and Shuttle Pharmaceuticals, and the top losers, including Outlook Therapeutics and Bio Green Med Solution, along with their respective percentage changes and market capitalizations.
